tm logo

Monitor this mark

View On USPTO

XERAVA
Live/Registered
REGISTERED

on 24 Sep 2019

Last Applicant/ Owned by

Tetraphase Pharmaceuticals, Inc.

201 Jones Road, Suite 400

Waltham

MA

02451

Serial Number

87782461 filed on 02th Feb 2018

Registration Number

5869102 registered on 24th Sep 2019

in the Principal Register

Correspondent Address

Jonathan M. Gelchinsky

Jonathan M. Gelchinsky Pierce Atwood LLP

Portland, ME 04101

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XERAVA

Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis

First Use Date in General

11th Oct 2018

First Use Date in Commerce

11th Oct 2018

Mark Details

Serial Number

No 87782461

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 32942/3009

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
24th Sep 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28th Sep 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
28th Sep 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28th Sep 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28th Sep 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
28th Sep 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
24th Sep 2019REGISTERED-PRINCIPAL REGISTER
22nd Aug 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
21st Aug 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21st Aug 2019STATEMENT OF USE PROCESSING COMPLETE